Stay updated with breaking news from Two Randomized. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Presentation to highlight baseline characteristics of Spruce’s CAHmelia program evaluating tildacerfont in adult congenital adrenal hyperplasia , as an illustration of outcomes of current pediatric...
Investigators believe targeted immunomodulation with SEL-212 may have the potential to introduce a new uricase-based therapy for patients with gout refractory to conventional treatment.
Almirall achieves core net sales of €633.8 MM Euros in the first nine months of 2022 showing a solid 5.3% growth Almirall continues solid business momentum in Q3 with an acceleration of sales
Almirall: Lebrikizumab’s 52-week late-breaking data will be presented at the 31st European Academy of Dermatology and Venereology (EADV) Congress The abstract entitled Efficacy and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: 52-Week Results of Two Randomized, Double-Blinded, Placebo-Co...